SIC
AMRX icon

SJS Investment Consulting’s Amneal Pharmaceuticals AMRX Stock Holding History

SJS Investment Consulting’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.37K Buy
541
+508
+1,539% +$6.96K ﹤0.01% 1107
2026
Q1 		$411 Buy
33
+16
+94% +$215 ﹤0.01% 1803
2025
Q4 		$215 Hold
17
– – ﹤0.01% 1785
2025
Q3 		$171 Buy
+17
New +$153 ﹤0.01% 1499
2025
Q2 		– Sell
-266
Closed -$2.23K – 1556
2025
Q1 		$2.23K Buy
266
+258
+3,225% +$2.15K ﹤0.01% 679
2024
Q4 		$64 Buy
+8
New +$67 ﹤0.01% 1547
2022
Q4 		– Sell
-4
Closed – – 1602
2022
Q3 		$0 Buy
+4
New +$11 ﹤0.01% 1023
2022
Q1 		$0 Buy
+1
New +$4 ﹤0.01% 693

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SJS Investment Consulting's AMRX Position: Q2 2026 in Review

SJS Investment Consulting increased its Amneal Pharmaceuticals (AMRX) stake by 1,539% in Q2 2026, buying an estimated $6.96K and bringing the position to 541 shares worth $9.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

SJS Investment Consulting first reported a position in AMRX in Q1 2022 and has held it in 8 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • SJS Investment Consulting held 541 shares of Amneal Pharmaceuticals worth $9.37K as of Q2 2026.
  • SJS Investment Consulting bought 508 Amneal Pharmaceuticals shares in Q2 2026, an estimated $6.96K.
  • Amneal Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1107 holding.
  • SJS Investment Consulting first reported a position in Amneal Pharmaceuticals in Q1 2022 and has held it in 8 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.